Evidence map›Paper›PMID 30571086›Full record

ArticleACS chemical biology2019

A Cancer-Selective Zinc Ionophore Inspired by the Natural Product Naamidine A.

Rachel M Vaden, Katrin P Guillen, Justin M Salvant, Celine B Santiago, Joseph B Gibbons, Satya S Pathi, Sasi Arunachalam, Matthew S Sigman, Ryan E Looper, Bryan E Welm

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Redox-Controlled Chalcogen Bonding as a Modulator of ZnClJournal of the American Chemical Society · 2026
    Article
  3. Review
  4. Review
  5. TargetingFrontiers in bioinformatics · 2025
    Article
  6. Organoids in breast cancer translational research: intersection of technologies.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review
  7. Article
  8. Article
  9. Rational Design of Silicon-Based Zinc Ionophores.Angewandte Chemie (International ed. in English) · 2022
    Article
  10. Article
  11. Targeting zinc metalloenzymes in coronavirus disease 2019.British journal of pharmacology · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rachel M VadenDepartment of Chemistry , University of Utah , 315 S 1400 E , Salt Lake City , Utah 84112 , United States.ORCID 0000-0001-7049-6345
Katrin P Guillen
Justin M SalvantDepartment of Chemistry , University of Utah , 315 S 1400 E , Salt Lake City , Utah 84112 , United States.ORCID 0000-0001-8359-8105
Celine B SantiagoDepartment of Chemistry , University of Utah , 315 S 1400 E , Salt Lake City , Utah 84112 , United States.
Joseph B GibbonsDepartment of Chemistry , University of Utah , 315 S 1400 E , Salt Lake City , Utah 84112 , United States.
Satya S Pathi
Sasi Arunachalam
Matthew S SigmanDepartment of Chemistry , University of Utah , 315 S 1400 E , Salt Lake City , Utah 84112 , United States.ORCID 0000-0002-5746-8830
Ryan E LooperDepartment of Chemistry , University of Utah , 315 S 1400 E , Salt Lake City , Utah 84112 , United States.ORCID 0000-0003-1626-1363
Bryan E Welm
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Synthetic and biological investigations of 2-aminoimidazole derived natural products.R01GM090082 · NIGMS · UNIVERSITY OF UTAH · PI LOOPER, RYAN EDWARD · 2010 to 2019
$2.6M
Identification of Novel Cancer Selective Compounds in 3D Tumor Organoid AssaysR01CA140296 · NCI · UNIVERSITY OF UTAH · PI SIGMAN, MATTHEW S · 2009 to 2013
$1.5M
Analysis of the Cellular Origins of Breast CancerR01CA143815 · NCI · UNIVERSITY OF UTAH · PI WELM, BRYAN E. · 2010 to 2014
$1.5M
NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA140296NCI NIH HHS R01 CA143815NIGMS NIH HHS R01 GM090082
6 · The paper itself

Abstract

We present data demonstrating the natural product mimic, zinaamidole A (ZNA), is a modulator of metal ion homeostasis causing cancer-selective cell death by specifically inducing cellular Zn

Indexed as

AnimalsCell ProliferationFemaleHumansImidazolesIonophoresMiceZincImidazolesIonophoresnaamidine AZinc

Identifiers

PMID30571086
PMCPMC8489793
OpenAlexW2906611342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.